Fennec Pharmaceuticals (FENC) Share-based Compensation Growth (5y) (2015 - 2025)
Fennec Pharmaceuticals (FENC) Share-based Compensation Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60.76% |
| Sep 30, 2025 | -47.37% |
| Jun 30, 2025 | -103.28% |
| Dec 31, 2024 | -16.05% |
| Sep 30, 2024 | 42.13% |
| Dec 31, 2023 | 96.84% |
| Sep 30, 2023 | 79.83% |
| Jun 30, 2023 | 98.27% |
| Mar 31, 2023 | 44.31% |
| Dec 31, 2022 | 45.20% |
| Sep 30, 2022 | -48.15% |
| Jun 30, 2022 | -40.29% |
| Mar 31, 2022 | 48.10% |
| Dec 31, 2021 | -49.78% |
| Sep 30, 2021 | 100.93% |
| Jun 30, 2021 | 139.01% |
| Dec 31, 2020 | 56.12% |
| Sep 30, 2020 | 167.73% |
| Dec 31, 2019 | -63.73% |
| Sep 30, 2019 | 36.20% |